FindTrial
Sign In

Chitosan: A novel dental dressing for shorter post extraction bleeding time in patients on blood thinning agents

EVALUATING THE ROLE OF CHITOSAN DERIVED DENTAL DRESSING FOR HEMOSTASIS AND WOUND HEALING IN PATIENTS ON ANTIPLATELET THERAPY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027016
Enrollment
50
Registered
2020-08-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K049- Other and unspecified diseases ofpulp and periapical tissues

Interventions

None listed

Sponsors

DR VARUN SHUKLA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients on oral antiplatelet drugs undergoing extractions Patients both male and female aged 35 to 75 years patients with two or more extraction sites for the purpose of study and control group patients who consent for the procedure patients with INR less than or equal to 3.5

Exclusion criteria

Exclusion criteria: Patients with poor diabetic control Patients with sea food allergy Patients not willing to accept the use of Chitosan as it is derived from freeze dried shrimps.

Design outcomes

Primary

MeasureTime frame
time to achieve hemostatsis alveolar osteitis and relative healingTimepoint: Immediately post extraction for hemostatis. 7 day post operatively for alveolar osteitis—

Secondary

MeasureTime frame
1 Incidence of allergy / reaction 2 Incidence of swelling, discomfort, infection or prolonged bleeding Timepoint: seven days post operatively—

Countries

India

Contacts

Public ContactVARUN SHUKLA

JSS DENTAL COLLEGE AND HOSPITAL

drsathish75@gmail.com7259617742

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026